COMPANY

Heligenics, Inc.

Location: Las Vegas, NV · source · Oct 12, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $801K (SBIR Phase II 5R44AI188872-02, continuation, notice Jun 11, 2026). NIH RePORTER 5R44AI188872-02 (Jun 11, 2026)
Evidence (1 event)
- Jun 11, 2026 · NIH RePORTER 5R44AI188872-02
  Organization: HELIGENICS INC; City/State: HENDERSON, NV; Project number: 5R44AI188872-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-11; FY total cost (award amount): 801133; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: High Content Screening for Bifunctional Chimera Biologics; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jun 11, 2026 Grant Government grant — SBIR: $801,133 (annual award, as published), announced Jun 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Dec 30, 2024 Grant Government grant — SBIR: $807,664 (annual award, as published), announced Dec 30, 2024. Agency: NIH/NIAID. Source: government award database. source ↗

Last 2 years.

Jun 11, 2026 Government grant — SBIR: $801,133 (annual award, as published), announced Jun 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Dec 30, 2024 Government grant — SBIR: $807,664 (annual award, as published), announced Dec 30, 2024. Agency: NIH/NIAID. Source: government award database. source ↗